Influence of Thymoglobuline on Phenotypic and Functional Profiles of B Lymphocytes in Renal Transplant Recipients

The investigators expect to better characterise B cell subpopulation and functional properties early after graft, to analyse effect of induction therapy (thymoglobulin versus basiliximab) on B cells, and to compare this B cell profiles with those obtained in our previous study in patients with chronic Antibody Mediated Rejection (cAMR)

Inclusion Criteria:

• Age >18 years old
• Recipient of a renal allograft
• Patient receiving either basiliximab or thymoglobulin as in induction therapy for renal transplant
• Patient presenting a low immunologic risk
• Patient not opposed to his (her) study participation

Exclusion Criteria:

• Patient participating in a clinical trial